Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $801.9 million.

  • Fresenius Medical Care AG's Consolidated Net Income rose 3199.52% to $382.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 642.63%. This contributed to the annual value of $801.9 million for FY2024, which is 175.0% up from last year.
  • As of FY2024, Fresenius Medical Care AG's Consolidated Net Income stood at $801.9 million, which was up 175.0% from $788.1 million recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Consolidated Net Income high stood at $1.6 billion for FY2020, and its period low was $788.1 million during FY2023.
  • For the 5-year period, Fresenius Medical Care AG's Consolidated Net Income averaged around $1.1 billion, with its median value being $942.6 million (2022).
  • In the last 5 years, Fresenius Medical Care AG's Consolidated Net Income surged by 176.16% in 2020 and then crashed by 3240.9% in 2022.
  • Over the past 5 years, Fresenius Medical Care AG's Consolidated Net Income (Annual) stood at $1.6 billion in 2020, then dropped by 14.94% to $1.4 billion in 2021, then crashed by 32.41% to $942.6 million in 2022, then decreased by 16.39% to $788.1 million in 2023, then rose by 1.75% to $801.9 million in 2024.
  • Its last three reported values are $801.9 million in FY2024, $788.1 million for FY2023, and $942.6 million during FY2022.